The progress on the use of botulinum toxin type A therapy in Parkinson′s disease / 中华神经科杂志
Chinese Journal of Neurology
;
(12): 70-76, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-933759
ABSTRACT
Botulinum toxin type A (BTX A) has gain widespread use in various neurological conditions, characterized by safe injection and less side-effect. This review will examine the current research of BTX A in the following aspects mechanism, location, dose and outcome, which manifests the safety and efficacy data of BTX A injection treatment to the symptoms of Parkinson disease, including refractory tremor, focal dystonia, loss of postural reflexes, sialorrhea, gastrointestinal symptoms and depressive disorder.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Neurology
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS